Biotechnology

Flywheel Healthcare is offers a range of pharmaceutical and clinical products and services.

DeepCure is transforming the field of small-molecule drug discovery, by delivering better drugs in a faster and more affordable way.

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).

MISSION Therapeutics offers a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes (DUBs).

SpeeDx is a provider of innovative multiplex and isothermal amplification solutions for clinical diagnostics.

GPN Vaccines is a biotechnology company developing a streptococcus pneumoniae vaccine. The company's vaccines includes life-threatening pneumonia, bacteremia, and meningitis, as well as otitis media.

Bactobio uses sequencing, machine learning, and cultivation techniques to harvest novel solutions from biological dark matter.

Signet Healthcare Partners is a leading provider of growth capital to innovative healthcare companies. Signet invests in commercial-stage healthcare companies that are revenue generating or preparing for commercial launch. Signet focuses primarily on the pharmaceutical and medical technology sector

Zybio is a leading Chinese developer, manufacturer dedicated in diagnostic reagents and equipment.

NS2 develops and implements innovative equipment and solutions that provide insight into critical biological activity.

EveryONE Medicines is committed to developing individualized precision medicines targeting genetic variants causing fatal, neurodegenerative diseases unique to just a few or even ONE patient. Momentum is building as technological advances with genomic testing and the prevalence of testing is improvi

Rex Health Ventures (RHV) enables groundbreaking work by investing in and fostering companies and technologies that advance the future of health. As an entrepreneur-friendly strategic investor, RHV accelerates access to new healthcare products and services to improve patient care. RHV was establishe

Caldera Medical is a privately held women‘s health medical device company focused on minimally invasive applications.

Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infect

Esco Lifesciences provides enabling technologies, products, and services.

Philogen is a Swiss-Italian integrated biotechnology company.

A biotech company specialized in the development, production, and commercialization of high added value active ingredients from the technology of plant stem cells, for cosmetics and dermo-cosmetics.

Developing best-in-class targeted therapies to improve the lives of patients.

Avance Clinical is a full-service contract research organisation offering a suite of clinical trial services to biotechnology and pharmaceutical companies globally.

Since 2008, i-Pharm’s independent, expert, and ethical approach to procuring talent has helped power the pioneering progress made by Pharmaceutical, Biotech and MedTech companies around the world. We have specialist teams working from offices in London, Munich, Frankfurt, New York, Charlotte, San Di

Bengaluru based biotech startup.

Noble creates intelligent materials designed to PROTECT, SAVE, HEAL, and IMPROVE LIVES

HEPQuant develops minimally invasive diagnostics for liver function.

Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.

Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

OriGen Biomedical, Inc. is a small, privately-held medical device manufacturer founded in 1997 and headquartered in Austin, Texas. They manufacture a range of products to treat respiratory distress, cancer, genetic conditions, and other life-threatening diseases.

VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies

Dr. Raj Krishnan founded Biological Dynamics in 2010 with the goal to revolutionize diagnosis and treatment of high burden diseases. Under Raj's vision and guidance, Biological Dynamics has transformed from concept to early-stage startup and is now one of the most innovative diagnostic companies in

Inotiv, Inc. is a leading contract research organization specializing in nonclinical and analytical drug discovery and development services.

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Three industry leading companies, MedQIA, WorldCare Clinical and DARC, have come together to form Voiant, the new leader in clinical trial imaging endpoint data. We are the industry leading AI-based clinical trial imaging solution with unparalleled scientific and clinical domain expertise, providin

CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic

Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.

Phoenix Molecular Designs is a biopharmaceutical company designing precise cancer therapeutics by targeting kinases.

BlueSphere Bio is a novel TCXpress technology to unlock the potential of personalized T-cell therapy for the treatment of cancer .

Eclipse Bioinnovations Inc. is a San Diego biotechnology start-up company focused on specialized genomics technologies. Their major focus is the development of next-generation sequencing products and services to profile binding sites for RNA binding proteins, using enhanced crosslinking and immunopr

MedTech connects New York State’s Bio/Med industry through collaboration, education and advocacy. They are an active association of pharmaceutical, biotech and medical technology companies, their suppliers and service providers, and research institutions.

Opthea Limited (formerly Circadian Technologies) is a public Australian biotechnology company developing novel biologic therapies for the treatment of eye diseases.

JB Ashtin is a pharmaceutical company offering medical communications planning and development services.

MiAlgae is a new-age microalgal production company .

Deepcell's mission is to enable novel biological insights at the single-cell level for improved diagnosis and treatment of disease.

Karius sees a world where infectious disease is no longer a major threat to human health. To achieve this, the Karius Test enables mapping of the patient’s microbial landscape from a single blood sample to enable physicians to make rapid treatment decisions.

USDM Life Sciences makes it easier to accelerate innovation and maximize human productivity.

Antibody Screening - Unravelling the full potential of entire immune repertoires (millions of B cells) VERAXA´s unique platform can combine the assessment of antibody binding with its functional capabilities in 1 single screening step, using a proprietary droplet-based microfluidic screening worksta

ProTide technology to transform some of the most widely prescribed chemotherapy / cancer agents

VISION IN SCIENTIFIC AND MEDICAL PUBLISHING Founded in 2001, Future Science Group is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. Future Science Group’s portfolio consists of two imprints, Future Science and Future Medicine. Both publish

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insi

Liverpool ChiroChem manufactures and supplies specialist building blocks for pharmaceutical research and biotechnology.